Ramirez-Correa Genaro A, Frazier Aisha H, Zhu Guangshuo, Zhang Pingbo, Rappold Thomas, Kooij Viola, Bedja Djahida, Snyder Greg A, Lugo-Fagundo Nahyr S, Hariharan Raena, Li Yuejin, Shen Xiaoxu, Gao Wei Dong, Cingolani Oscar H, Takimoto Eiki, Foster D Brian, Murphy Anne M
Department of Pediatrics and Division of Pediatric Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland;
Department of Medicine and Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland;
J Appl Physiol (1985). 2015 Jan 15;118(2):212-23. doi: 10.1152/japplphysiol.00463.2014. Epub 2014 Oct 16.
Troponin I (TnI) variant Pro82Ser (cTnIP82S) was initially considered a disease-causing mutation; however, later studies suggested the contrary. We tested the hypothesis of whether a causal link exists between cTnIP82S and cardiac structural and functional remodeling, such as during aging or chronic pressure overload. A cardiac-specific transgenic (Tg) mouse model of cTnIP82S was created to test this hypothesis. During aging, Tg cTnIP82S displayed diastolic dysfunction, characterized by longer isovolumetric relaxation time, and impaired ejection and relaxation time. In young, Tg mice in vivo pressure-volume loops and intact trabecular preparations revealed normal cardiac contractility at baseline. However, upon β-adrenergic stimulation, a blunted contractile reserve and no hastening in left ventricle relaxation were evident in vivo, whereas, in isolated muscles, Ca(2+) transient amplitude isoproterenol dose-response was blunted. In addition, when exposed to chronic pressure overload, Tg mice show exacerbated hypertrophy and decreased contractility compared with age-matched non-Tg littermates. At the molecular level, this mutation significantly impairs myofilament cooperative activation. Importantly, this occurs in the absence of alterations in TnI or myosin-binding protein C phosphorylation. The cTnIP82S variant occurs near a region of interactions with troponin T; therefore, structural changes in this region could explain its meaningful effects on myofilament cooperativity. Our data indicate that cTnIP82S mutation modifies age-dependent diastolic dysfunction and impairs overall contractility after β-adrenergic stimulation or chronic pressure overload. Thus cTnIP82S variant should be regarded as a disease-modifying factor for dysfunction and adverse remodeling with aging and chronic pressure overload.
肌钙蛋白I(TnI)变体Pro82Ser(cTnIP82S)最初被认为是一种致病突变;然而,后来的研究表明情况并非如此。我们测试了一个假设,即cTnIP82S与心脏结构和功能重塑之间是否存在因果联系,比如在衰老或慢性压力超负荷期间。为了验证这一假设,构建了一种心脏特异性的cTnIP82S转基因(Tg)小鼠模型。在衰老过程中,Tg cTnIP82S小鼠表现出舒张功能障碍,其特征为等容舒张时间延长,射血和舒张时间受损。在年轻的Tg小鼠体内,压力-容积环和完整小梁标本显示基线时心脏收缩功能正常。然而,在β-肾上腺素能刺激下,体内明显出现收缩储备减弱且左心室舒张未加速的情况,而在分离的肌肉中,异丙肾上腺素剂量反应的Ca(2+)瞬变幅度减弱。此外,与年龄匹配的非Tg同窝小鼠相比,当暴露于慢性压力超负荷时,Tg小鼠表现出更严重的肥大和收缩力下降。在分子水平上,这种突变显著损害肌丝协同激活。重要的是,这一现象发生在TnI或肌球蛋白结合蛋白C磷酸化没有改变的情况下。cTnIP82S变体出现在与肌钙蛋白T相互作用区域附近;因此,该区域的结构变化可以解释其对肌丝协同性的显著影响。我们的数据表明,cTnIP82S突变会改变年龄依赖性舒张功能障碍,并损害β-肾上腺素能刺激或慢性压力超负荷后的整体收缩力。因此,cTnIP82S变体应被视为衰老和慢性压力超负荷导致功能障碍及不良重塑的疾病修饰因子。